glyburide has been researched along with Central Nervous System Neoplasms in 1 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous glyburide has demonstrated safety when used for attenuation of cerebral edema, although safety data are lacking for enteral glyburide when used for this indication." | 8.02 | Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients. ( Armahizer, MJ; Howard, AK; Kalasapudi, L; Morris, NA; Sansur, C; Seung, H, 2021) |
| "Intravenous glyburide has demonstrated safety when used for attenuation of cerebral edema, although safety data are lacking for enteral glyburide when used for this indication." | 4.02 | Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients. ( Armahizer, MJ; Howard, AK; Kalasapudi, L; Morris, NA; Sansur, C; Seung, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armahizer, MJ | 1 |
| Howard, AK | 1 |
| Seung, H | 1 |
| Kalasapudi, L | 1 |
| Sansur, C | 1 |
| Morris, NA | 1 |
1 other study available for glyburide and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients.
Topics: Administration, Oral; Adult; Aged; Body Mass Index; Brain Edema; Central Nervous System Neoplasms; C | 2021 |